Diane O’Neil v. Somatics, LLC & Elektrika, Inc.

2021 DNH 151
CourtDistrict Court, D. New Hampshire
DecidedSeptember 24, 2021
Docket20-cv-175-PB
StatusPublished
Cited by3 cases

This text of 2021 DNH 151 (Diane O’Neil v. Somatics, LLC & Elektrika, Inc.) is published on Counsel Stack Legal Research, covering District Court, D. New Hampshire primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Diane O’Neil v. Somatics, LLC & Elektrika, Inc., 2021 DNH 151 (D.N.H. 2021).

Opinion

UNITED STATES DISTRICT COURT FOR THE DISTRICT OF NEW HAMPSHIRE

Diane O’Neil Case No. 20-cv-175-PB v. Opinion No. 2021 DNH 151

Somatics, LLC & Elektrika, Inc.

MEMORANDUM AND ORDER

In this diversity action, Diane O’Neil, a New Hampshire

resident, has sued two out-of-state corporate defendants,

Somatics, LLC and Elektrika, Inc., after sustaining injuries

from electroconvulsive therapy with a Thymatron instrument. I

allowed O’Neil to conduct jurisdictional discovery when

Elektrika first moved to dismiss the claims against it for lack

of personal jurisdiction. Before me is Elektrika’s renewed

motion to dismiss on the same ground. Because O’Neil has failed

to demonstrate that Elektrika is subject to personal

jurisdiction in New Hampshire, I grant the motion to dismiss.

I. BACKGROUND

The Thymatron is an instrument used to treat severe

psychiatric disturbances by inducing a major motor seizure

through a brief but intense electrical current applied to a

patient’s head in a process known as electroconvulsive therapy.

From August 2016 until February 2017, O’Neil underwent multiple

rounds of electroconvulsive therapy with a Thymatron at the Elliot Hospital in Manchester, New Hampshire. She allegedly

suffered brain damage and permanent neurocognitive injuries as a

result of that treatment.

Since its inception in the 1980s, the Thymatron has been

collaboratively designed and manufactured by Elektrika, a

privately held New York corporation, and Somatics, a Florida

limited liability company. There is no overlap in ownership

between the two companies. According to a 1997 exclusivity

agreement between Elektrika and Somatics, the two “have enjoyed

an exclusive and successful business relationship since 1983,

characterized by close collaboration in the design, manufacture,

and marketing of the Thymatron ECT device and accessories

worldwide.” Doc. No. 34 at 3. In that contract, Elektrika

agreed to manufacture the Thymatron exclusively for Somatics, so

long as Somatics purchases at least fifty units every year. In

turn, Somatics agreed to purchase the device exclusively from

Elektrika, provided that Elektrika supplies as many units as

Somatics “provides good purchase orders for.” Doc. No. 34 at 3.

Elektrika is the principal designer and manufacturer of the

device. Elektrika designed the original Thymatron and has been

responsible for design updates, with Somatics suggesting some

specifications that Elektrika could reject. In terms of

manufacturing, Elektrika assembles the main body of the device

in New York and ships it to Somatics in Florida. Somatics

2 completes the assembly by installing additional parts and

calibrating the device.

Somatics is exclusively responsible for the sale and

distribution of the Thymatron. At least since 2003, Somatics

has marketed the device without any input from Elektrika.

An undated agreement between the two companies regarding

quality assurance practices provides that Elektrika is

“responsible for handling any repairs of the Thymatrons sent to

be serviced and reporting the information to Somatics who will

be responsible for maintaining the repair / Customer Complaint

procedures.” Doc. No. 34 at 2. Throughout the repair process,

Somatics is the only entity that communicates with a Thymatron

customer, such as a hospital. The process starts when a

hospital contacts Somatics with a maintenance or repair request.

Somatics assigns a return merchandise authorization (“RMA”)

number to the machine in question and coordinates its transfer

to Elektrika. Typically, Somatics instructs the hospital to

ship the device either directly to Elektrika’s New York location

or to Somatics, which then forwards it to Elektrika. Upon

receipt, Elektrika verifies that the machine is accompanied by

an RMA issued by Somatics, examines the machine, and informs

Somatics what work needs to be done. After Somatics approves

the proposed repair work, Elektrika completes the repair and

returns the machine. A packing slip provided by Somatics tells

3 Elektrika where and how to ship the repaired machine, typically

either back to Somatics or directly to the hospital. Somatics

bills the hospital for the repair and remits payment to

Elektrika.

The specific device that injured O’Neil was manufactured in

2005. Elektrika has performed maintenance or repair work on

that machine on three occasions, in June 2008, January 2010, and

June 2020. On each occasion, Elektrika received the machine and

performed the work in New York. Elektrika then shipped it back

directly to the Elliot Hospital in New Hampshire.

In September 2013, Elektrika shipped a Thymatron component

part directly to another hospital in New Hampshire, the Southern

New Hampshire Medical Center. That hospital placed the part

order with Somatics, which later remitted payment to Elektrika.

Elektrika has no offices, facilities, employees, agents, or

other representatives in New Hampshire. It does, however,

purchase printer cables, which are incorporated into the

Thymatron, from a New Hampshire-based sales representative of a

California company called Rapid Manufacturing. 1 For the past ten

years, Elektrika has placed via email approximately one order

for 200 printer cables every year, paying around $1,000 per

order.

1 The cables are used to connect the printer to the PC board in the Thymatron instrument.

4 The complaint alleges product liability and negligence

claims against Elektrika. Specifically, Elektrika is allegedly

liable for a negligent failure to warn, manufacturing and design

defects, breach of the implied warranty of merchantability, and

breach of the implied warranty of fitness. These theories of

liability center on the idea that the Thymatron device is an

inherently dangerous and defective device that was not

accompanied by adequate warnings about the risks of undergoing

electroconvulsive therapy.

After the complaint was filed, Elektrika moved to dismiss

the claims against it for lack of personal jurisdiction. O’Neil

responded with a request to conduct jurisdictional discovery. I

denied without prejudice Elektrika’s motion and granted O’Neil’s

request for limited jurisdictional discovery after concluding

that she had proffered a colorable claim that Elektrika is

subject to specific jurisdiction in New Hampshire. After the

parties conducted that discovery, Elektrika renewed its motion

to dismiss for lack of personal jurisdiction. I held a hearing

on the motion in June 2021. At the hearing, both parties agreed

that I could decide the present motion on the record before me,

without conducting an evidentiary hearing.

II. STANDARD OF REVIEW

When defendant contests personal jurisdiction under Federal

Rule of Civil Procedure 12(b)(2), plaintiff bears the burden of

5 showing that a basis for asserting jurisdiction exists. Nandjou

v. Marriott Int’l, Inc., 985 F.3d 135, 147 (1st Cir. 2021).

Where, as here, the court considers a Rule 12(b)(2) motion

without holding an evidentiary hearing, the court applies the

prima facie standard. See id. Under this standard, plaintiff

Free access — add to your briefcase to read the full text and ask questions with AI

Related

O'Neil v. Somatics, LLC
D. New Hampshire, 2021

Cite This Page — Counsel Stack

Bluebook (online)
2021 DNH 151, Counsel Stack Legal Research, https://law.counselstack.com/opinion/diane-oneil-v-somatics-llc-elektrika-inc-nhd-2021.